Cite
MLA Citation
Beatrice Seddon et al.. “Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.” Lancet oncology, vol. 18, no. 10, n.d., pp. 1397–1410. http://access.bl.uk/ark:/81055/vdc_100050154261.0x000006